Dong A St Co., Ltd - Jun 23, 2024 Form 4/A Insider Report for NeuroBo Pharmaceuticals, Inc. (NRBO)

Role: 10%+ Owner
Signature: Dong-A St Co., Ltd.; By: /s/ Min Young Kim, Chief Executive Officer
Stock symbol: NRBO
Transactions as of: Jun 23, 2024
Transactions value $: $10,000,003
Form type: 4/A
Date filed: 7/10/2024, 11:11 AM
Date Of Original Report: Jun 25, 2024
Next filing: Sep 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRBO	Common Stock	Purchase	$10M	+2.54M	+90.76%	$3.93	5.35M	Jun 23, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.

Content

This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.